Navigation Links
Researcher receives lectureship for lifetime achievements
Date:4/4/2011

Cleveland Clinic biochemist George R. Stark, Ph.D., has been awarded the American Society for Biochemistry and Molecular Biology's (ASBMB) 2011 Herbert Tabor/Journal of Biological Chemistry Lectureship.

Stark is the Distinguished Scientist of Cleveland Clinic's Lerner Research Institute and Emeritus Professor of Genetics at Case Western Reserve University.

"George Stark has been a leader and pioneer in basic and applied research," said Charles E. Samuel, Ph.D., the C.A. Storke II Professor of biochemistry and virology at the University of California, Santa Barbara, and longtime colleague of Stark. "He has been a superb scientist personifying many of the characteristics of Herb Tabor. Recognition with our Society's Herbert Tabor Lectureship is a most fitting tribute to Stark's numerous seminal contributions."

The lectureship recognizes outstanding lifetime scientific achievements and was established to honor the many contributions of Dr. Herbert Tabor to both the ASBMB and the Journal of Biological Chemistry, where he has served as editor for nearly 40 years. Stark will be the eighth person so honored, joining previous recipients, which include a Nobel Laureate.

Stark said, "It is wonderfully gratifying to be recognized by one's peers, and it is a special privilege to be associated in this way with Herb Tabor and the previous Tabor lecturers."

Stark's contributions span many fields, influencing the understanding not only of basic biochemistry, but also gene regulation and cell signaling, having implications regarding immunity and cancer. These discoveries began during his early work on enzyme mechanisms and protein chemistry, where he developed the well known Northern and Western techniques, which detect specific nucleic acids and proteins, respectively. These techniques are now used worldwide by scientists in research, as well as in clinical testing applications. More recently, Stark is attributed with co-discovering gene amplification in mammalian cells and the Jak-Stat signaling cascade, a major pathway mediating cellular responses to signals sent by the immune system.

A native of New York City, Stark earned his Ph.D. in chemistry from Columbia University in 1959. He then served as a research associate and assistant professor at Rockefeller University with biochemists and Nobel laureates William Stein and Stanford Moore. After moving to Stanford University in 1963, he became a full professor of biochemistry in 1971. From 1983 to 1992, he worked at the Imperial Cancer Research Fund in London (now Cancer Research UK) as a senior scientist and later associate director of research. In 1992, he relocated to Cleveland Clinic, where he served as Chair of the Lerner Research Institute until 2002, and where he continues his research today.

Stark will present his award lecture at ASBMB's annual meeting's opening session on Saturday, April 9, 2011, in Washington, D.C.


'/>"/>

Contact: Dan Doron
dorond@ccf.org
216-312-0428
Lerner Research Institute
Source:Eurekalert

Related biology news :

1. Wistar Institute researcher receives New Innovator award from NIH
2. NC State researchers get to root of parasite genome
3. Researchers find animal with ability to survive climate change
4. Researchers find an essential gene for forming ears of corn
5. Researchers note differences between people and animals on calorie restriction
6. Researcher working on destruction of chemical weapons
7. Researchers study acoustic communication in deep-sea fish
8. Researchers discover that growing up too fast may mean dying young in honey bees
9. Researchers study how pistachios may improve heart health
10. UI researchers find potentially toxic substance present in Chicago air
11. Researchers develop new self-training gene prediction program for fungi
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/14/2017)... 14, 2017  Wake Forest Baptist Medical Center today ... chief executive officer (CEO). Freischlag joins the medical center ... McConnell , M.D., who last year announced that he ... Center, after leading it since 2008.   ... Wake Forest Baptist,s academic health system, which includes Wake ...
(Date:2/10/2017)... DUBLIN , Feb 10, 2017 ... PharmaBiotech,s new report "Personalized Medicine - Scientific and Commercial ... ... in personalized medicine. Diagnosis is integrated with therapy for selection ... emphasis on early detection and prevention of disease in modern ...
(Date:2/8/2017)... 7, 2017  Aware, Inc. (NASDAQ: AWRE ), ... financial results for its quarter and year ended December 31, ... 2016 was $3.9 million compared to $6.9 million in the ... of 2016 was $0.6 million compared to $2.6 million in ... quarter of 2016 was $0.5 million, or $0.02 per diluted ...
Breaking Biology News(10 mins):
(Date:2/24/2017)... (NASDAQ: VWR), the leading global independent provider of product and ... financial results for the fourth quarter and full year ended ... 4Q16 record quarterly net sales of $1.13 billion, up 1.6% ... 4Q16 EMEA-APAC segment net sales increased 0.4%, ... sales increased 2.5%, or down 0.9% on an organic basis, ...
(Date:2/23/2017)... - The Fight Against Cancer Innovation Trust (FACIT) and ... to report that Fusion Pharmaceuticals Inc. (Fusion) has closed ... Innovation – JJDC, Inc. (JJDC) as the lead investor. ... Partners, and Genesys Capital, as well as founding investor ... ...
(Date:2/23/2017)... ... February 23, 2017 , ... Brain ... to begin marketing the SPEAC® System, the Brain Sentinel® Seizure Monitoring and Alerting ... in healthcare facilities during periods of rest. A lightweight, non-invasive monitor is placed ...
(Date:2/23/2017)... Therapeutics, Inc. (NASDAQ: CAPR), a biotechnology company developing biological therapies ... Marbán, Ph.D, president and chief executive officer, is scheduled to ... Cowen and Company 37th Annual Health Care Conference Tuesday, March ... 29th Annual ROTH Conference Tuesday, ... Dana Point, CA ...
Breaking Biology Technology: